[PHAS] QoQ Quarter Result on 30-Sep-2017 [#Q3]

Stock
[PHAS] PhaseBio Pharmaceuticals, Inc.
Announcement Date
29-Sep-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ-
YoY-
Quarter Report
PHAS's Result
PHAS's Financial Summary
View:
Show?
Quarter Result
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
Revenue 653 257 411 0 0 0 0 -
PBT -7,293 -4,868 -7,901 -6,674 -4,403 -2,535 -2,560 101.08%
Tax 317 2,975 -2,012 -1,120 -121 1,034 -47 -
NP -7,293 -4,868 -7,901 -6,674 -4,403 -2,535 -2,560 101.08%
Tax Rate - - - - - - - -
Total Cost 7,946 5,125 8,312 6,674 4,403 2,535 2,560 112.93%
Ratio Analysis
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
NP Margin -1,116.85 -1,894.16 -1,922.38 0.00 0.00 0.00 0.00 -
Per Share
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
EPS -0.30 -0.26 -0.40 -0.34 -0.36 -0.20 -0.21 26.87%
EPS Diluted -0.30 -0.26 -0.40 -0.34 -0.36 -0.20 -0.21 26.87%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.